drug · small molecule
lanifibranor
Phase 3updated 5mo agoby Inventiva SA🔗 ChEMBL
Phase 3community read0 votes
🐶 often sniffed alongside
top 3Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 3 investigational indications.
targets
Peroxisome proliferator-activated receptor
all catalysts(1)
Trials studying lanifibranor
- phase2Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus
- phase2Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease
- phase1A Pharmacokinetic Study of Lanifibranor in Healthy Adult Chinese Subjects
News(1)
- Chutes & Ladders—Invivyd's chairman adds CEO role ahead of COVID readoutInfectious-disease biotech Invivyd has appointed its current chairman, Marc Elia, as CEO.fiercebiotech · 1mo ago
Data sources
last refreshed 10m ago
Found something off?
comments(0)
5-min edit window · permanent after that